FIGURE 1.
Efficacy of eculizumab (response analysis set). Percent change from baseline in (A) MG‐ADL total score and (B) QMG total score. Data are least‐squares mean ± 95% confidence interval estimates. MG‐ADL, Myasthenia Gravis‐Activities of Daily Living; QMG, Quantitative Myasthenia Gravis.